All (n = 415) | Male (n = 170) | Female (n = 245) | p-value | ||
---|---|---|---|---|---|
Age | 53.6 ± 18.1 | 56.2 ± 16.7 | 51.8 ± 18.9 | 0.015a | |
≤39 | 91 | 29 | 62 | 0.001b | |
40s | 81 | 33 | 48 | 0.096b | |
50s | 62 | 27 | 35 | 0.310b | |
60s | 89 | 38 | 51 | 0.168b | |
≥70 | 92 | 43 | 49 | 0.532b | |
GLFS-25(+) | 337 (81.2%) | 136 (80.0%) | 201 (82.0%) | 0.601b | |
≤39 | 69 (75.8%) | 24 (82.8%) | 45 (72.6%) * | 0.291b | |
40s | 64 (79.0%) | 26 (78.8%) | 38 (79.1%) | 0.967b | |
50s | 48 (77.4%) | 19 (70.4%) | 29 (82.9%) | 0.244b | |
60s | 73 (82.0%) | 31 (86.1%) | 42 (82.3%) | 0.925b | |
≥70 | 83 (90.2%) | 36 (83.7%) | 47 (95.9%) ** | 0.077c | |
Total score of the GLFS-25 | 33 (19–49) | 32.5 (18–45) | 34 (20–52) | 0.525d | |
Body pain | 8 (6–11) | 8 (5–11) | 8 (6–11) | 0.774d | |
Movement-related difficulty | 3 (1–4) | 3 (1–4) | 2 (0–5) | 0.621d | |
Usual care | 2 (0–6) | 3 (0–6) | 2 (0–6) | 0.381d | |
Social participation | 8 (4–12) | 8 (4–11) | 8 (4–12) | 0.331d | |
Anxiety | 2 (0–4) | 1.5 (0–4) | 2 (0–4) | 0.484d | |
Average NRS | 6 (4–7) | 6 (4–7) | 6 (5–7) | 0.958d | |
HADS | 16 (10–22) | 16 (11–21) | 16 (10–22) | 0.966d | |
PCS | 35 (27–41) | 36 (27–42) | 35 (27–41) | 0.665d | |
PSEQ | 26 (17–36) | 26 (17–36) | 27 (17–37) | 0.552d | |
EQ-5D | 0.59 (0.47–0.66) | 0.58 (0.47–0.66) | 0.59 (0.47–0.66) | 0.706d |